DiaSorin S.p.A. (DSRLF)
USD 106.85
(0.0%)
USD 106.85
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.31 Billion USD | -9.02% |
| 2022 | 1.44 Billion USD | -8.75% |
| 2021 | 1.58 Billion USD | 3639.35% |
| 2020 | 42.4 Million USD | 29.04% |
| 2019 | 32.86 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 808.24 Million EUR | -36.73% |
| 2024 Q2 | 1.02 Billion EUR | 37.4% |
| 2023 Q4 | 1.18 Billion EUR | 4.16% |
| 2023 FY | 1.31 Billion USD | -9.02% |
| 2023 Q2 | 1.3 Billion USD | -1.37% |
| 2023 Q3 | 1.13 Billion EUR | -13.02% |
| 2023 Q1 | 1.32 Billion EUR | -8.45% |
| 2022 Q3 | 1.38 Billion EUR | -3.19% |
| 2022 FY | 1.44 Billion USD | -8.75% |
| 2022 Q1 | 1.52 Billion EUR | 9.56% |
| 2022 Q2 | 1.43 Billion EUR | -6.37% |
| 2022 Q4 | 1.44 Billion USD | 4.43% |
| 2021 Q2 | 528.28 Million EUR | 1138.0% |
| 2021 FY | 1.58 Billion USD | 3639.35% |
| 2021 Q3 | 1.59 Billion EUR | 201.47% |
| 2021 Q4 | 1.39 Billion EUR | -12.4% |
| 2021 Q1 | 42.67 Million EUR | 23.12% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q3 | 32.24 Million EUR | 19.57% |
| 2020 Q4 | 34.66 Million EUR | 7.48% |
| 2020 FY | 42.4 Million USD | 29.04% |
| 2020 Q2 | 26.96 Million EUR | 0.0% |
| 2019 FY | 32.86 Million USD | 0.0% |
| 2019 Q4 | 29.27 Million EUR | 219.76% |
| 2019 Q3 | 9.15 Million EUR | -88.84% |
| 2019 Q2 | 82.02 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q4 | 24.3 Million EUR | 68.83% |
| 2018 Q3 | 14.39 Million EUR | -11.23% |
| 2018 Q2 | 16.21 Million EUR | 255.8% |
| 2018 Q1 | 4.55 Million EUR | -84.18% |
| 2017 Q4 | 28.8 Million EUR | 480.36% |
| 2017 Q2 | 45.45 Million EUR | -27.42% |
| 2017 Q1 | 62.62 Million EUR | 0.33% |
| 2017 Q3 | 4.96 Million EUR | -89.08% |
| 2016 Q2 | 74.73 Million EUR | 2750.61% |
| 2016 Q1 | 2.62 Million EUR | -1.23% |
| 2016 Q3 | 72.02 Million EUR | -3.63% |
| 2016 Q4 | 62.42 Million EUR | -13.33% |
| 2015 Q1 | 4.39 Million EUR | 4.45% |
| 2015 Q4 | 2.65 Million EUR | 7.04% |
| 2015 Q3 | 2.47 Million EUR | -23.58% |
| 2015 Q2 | 3.24 Million EUR | -26.17% |
| 2014 Q1 | 9.88 Million EUR | 0.08% |
| 2014 Q2 | 4.81 Million EUR | -51.3% |
| 2014 Q3 | 4.21 Million EUR | -12.48% |
| 2014 Q4 | 4.2 Million EUR | -0.19% |
| 2013 Q2 | 11.22 Million EUR | -31.59% |
| 2013 Q3 | 11.28 Million EUR | 0.58% |
| 2013 Q1 | 16.4 Million EUR | 0.0% |
| 2013 Q4 | 9.88 Million EUR | -12.46% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -58666.961% |
| Arrayit Corporation | 1.07 Million USD | -121994.251% |
| Atlantic International Corp. | 2.93 Million USD | -44820.176% |
| Biocept, Inc. | 12.1 Million USD | -10771.087% |
| Bioqual, Inc. | 3.58 Million USD | -36598.785% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -1812745.904% |
| DermTech, Inc. | 54.39 Million USD | -2320.083% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | -178.972% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -27131.984% |
| iMD Companies, Inc. | 1.12 Million USD | -117418.288% |
| IDenta Corp. | 789.14 Thousand USD | -166710.695% |
| Interpace Biosciences, Inc. | 11.19 Million USD | -11661.793% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -3002249.014% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -16262.884% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -34307.156% |
| NovelStem International Corp. | 3.57 Million USD | -36725.947% |
| Optigenex Inc. | 8.94 Million USD | -14623.396% |
| PharmChem, Inc. | 77.35 Thousand USD | -1701682.639% |
| Proteome Sciences plc | 17.15 Million USD | -7574.04% |
| Response Genetics, Inc | 6.37 Million USD | -20555.577% |
| Rennova Health, Inc. | 15.32 Million USD | -8487.319% |
| RushNet, Inc. | 4.82 Million USD | -27193.233% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -635727.895% |
| Stella Diagnostics Inc. | 6.2 Million USD | -21129.589% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -73028.846% |
| Todos Medical Ltd. | 38.34 Million USD | -3332.721% |